Advertisement

Topics

Can SBRT Improve Immunotherapy Outcomes in Metastatic NSCLC?

20:00 EDT 11 Jul 2019 | Cancer Networks

A new study examined whether stereotactic body radiotherapy prior to pembrolizumab improved response rate in lung cancer patients.

Original Article: Can SBRT Improve Immunotherapy Outcomes in Metastatic NSCLC?

NEXT ARTICLE

More From BioPortfolio on "Can SBRT Improve Immunotherapy Outcomes in Metastatic NSCLC?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...